You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » ALS (Lou Gehrig's Disease)
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
home:diseases:als [02.11.2019] – [Patient experiences] sallieqhome:diseases:als [09.14.2022] (current) – external edit 127.0.0.1
Line 6: Line 6:
 Lou Gehrig was known as The Gentleman of Baseball.  He played for the NY Yankees in the '20s and '30s.  He had **Amyotrophic Lateral Sclerosis** (ALS) and, because of his fame and courage in fighting it, the disease also became known as Lou Gehrig's Disease.  They made a movie about his life and his famous speech telling his beloved fans he had to quit.  Lou Gehrig was known as The Gentleman of Baseball.  He played for the NY Yankees in the '20s and '30s.  He had **Amyotrophic Lateral Sclerosis** (ALS) and, because of his fame and courage in fighting it, the disease also became known as Lou Gehrig's Disease.  They made a movie about his life and his famous speech telling his beloved fans he had to quit. 
  
-Here is [[http://en.wikipedia.org/wiki/Lou_Gehrig|his bio]].+Here is [[https://en.wikipedia.org/wiki/Lou_Gehrig|his bio]].
  
-A Washington Post columnist [[http://www.washingtonpost.com/wp-dyn/articles/A19187-2005Apr1.html|recently reviewed]] a new book about Lou Gehrig. He included an interesting quote from the book, "Luckiest Man: The Life and Death of Lou Gehrig" by Jonathan Eig, explaining that Gehrig's untimely death at age 39 from ALS changed it from an almost-unknown disease to a near-universally known disease.+A Washington Post columnist [[https://www.washingtonpost.com/wp-dyn/articles/A19187-2005Apr1.html|recently reviewed]] a new book about Lou Gehrig. He included an interesting quote from the book, "Luckiest Man: The Life and Death of Lou Gehrig" by Jonathan Eig, explaining that Gehrig's untimely death at age 39 from ALS changed it from an almost-unknown disease to a near-universally known disease.
  
 Lida Mattman's slides of ALS blood show very aggressive CWD-bacteria. Dr. Mattman suggested that the bacteria causing ALS multiply rapidly and are, therefore, very aggressive. It isn't known if that translates into their being resistant to the MP or readily killed. Or if they are easily killed, if they would release more endotoxins. All these unknowns mean that treating ALS with the MP will have to be done very carefully. It is best in these situations for Dr to discuss the actual case with Dr Marshall. Lida Mattman's slides of ALS blood show very aggressive CWD-bacteria. Dr. Mattman suggested that the bacteria causing ALS multiply rapidly and are, therefore, very aggressive. It isn't known if that translates into their being resistant to the MP or readily killed. Or if they are easily killed, if they would release more endotoxins. All these unknowns mean that treating ALS with the MP will have to be done very carefully. It is best in these situations for Dr to discuss the actual case with Dr Marshall.
Line 42: Line 42:
 Neuropharmacology Vol.13 No 8 12 June 2002 Ludo Van Den Bosch, Petra Tilkin, Griet Lemmns and Wim Robberecht Laboratory of Neurology, Campus Gasthuisberg, Herestraat 49, B-3000, Leuven, Belium Neuropharmacology Vol.13 No 8 12 June 2002 Ludo Van Den Bosch, Petra Tilkin, Griet Lemmns and Wim Robberecht Laboratory of Neurology, Campus Gasthuisberg, Herestraat 49, B-3000, Leuven, Belium
  
-<blockquote>[[http://www.labspaces.net/107755/Mysterious_cells_may_play_role_in_ALS|Mysterious cells may play role in ALS]]+<blockquote>[[https://www.labspaces.net/107755/Mysterious_cells_may_play_role_in_ALS|Mysterious cells may play role in ALS]]
  
 Although we found that the potential of these cells is more limited than previously thought, it might be possible to coax them to adopt different fates," Bergles says. "We only need to know what factors are restricting their development in the intact nervous system. Although we found that the potential of these cells is more limited than previously thought, it might be possible to coax them to adopt different fates," Bergles says. "We only need to know what factors are restricting their development in the intact nervous system.
Line 64: Line 64:
   * Chris Mavo:   * Chris Mavo:
  
-//Last contact: July, 2018// see [[http://www.marshallprotocol.com/forum30/13432.html|summary thread]]  [[https://www.marshallprotocol.com/forum35/13463.html|progress thread]]+//Last contact: July, 2018// see [[https://www.marshallprotocol.com/forum30/13432.html|summary thread]]  [[https://www.marshallprotocol.com/forum35/13463.html|progress thread]]
  
  
Line 89: Line 89:
  
  
-Marijuana is a substance with many properties that may be applicable to the management of amyotrophic lateral sclerosis (({{pubmed>long:11467101}})) +Marijuana is a substance with many properties that may be applicable to the management of amyotrophic lateral sclerosis (({{pmid>long:11467101}})) 
  
 Be aware that cannibinoids are immune suppressant. Be aware that cannibinoids are immune suppressant.
Line 95: Line 95:
 ===== Research notes ===== ===== Research notes =====
  
-<blockquote>All this frenetic oligodendrocyte-generating activity takes place in the central nervous system's gray matter where other cells — the motor neurons — are dying. A body of research shows that after acute trauma to the central nervous system, a short-term upswing in NG2+ activity takes place that may help reduce the extent of damage. Whether this change in behavior of NG2+ cells is protective, or accelerates the death of motor neurons in ALS, is not yet known.  //[[http://www.labspaces.net/107755/Mysterious_cells_may_play_role_in_ALS|Thanks to Johns Hopkins Medical Institutions for this article.]] // 2010</blockquote>+<blockquote>All this frenetic oligodendrocyte-generating activity takes place in the central nervous system's gray matter where other cells — the motor neurons — are dying. A body of research shows that after acute trauma to the central nervous system, a short-term upswing in NG2+ activity takes place that may help reduce the extent of damage. Whether this change in behavior of NG2+ cells is protective, or accelerates the death of motor neurons in ALS, is not yet known.  //[[https://www.labspaces.net/107755/Mysterious_cells_may_play_role_in_ALS|Thanks to Johns Hopkins Medical Institutions for this article.]] // 2010</blockquote>
  
 {{tag>diseases neurological }} {{tag>diseases neurological }}
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
  
-this link is to old TH1 thread  [[http://www.marshallprotocol.com/forum19/13414.html|getting started]] for Chris Mavo, pity we do not have access to GET CONTENT+this link is to old TH1 thread  [[https://www.marshallprotocol.com/forum19/13414.html|getting started]] for Chris Mavo, pity we do not have access to GET CONTENT
  
 <DiseaseHierarchy> <DiseaseHierarchy>
Line 106: Line 107:
  
   * Legacy content   * Legacy content
-  * [[http://www.marshallprotocol.com/view_topic.php?id=2697&forum_id=37&jump_to=37083#p37083]] e245 +  * [[https://www.marshallprotocol.com/view_topic.php?id=2697&forum_id=37&jump_to=37083#p37083]] e245 
-  * [[http://www.marshallprotocol.com/forum37/9805.html#p113372]] s322 +  * [[https://www.marshallprotocol.com/forum37/9805.html#p113372]] s322 
-  * [[http://www.marshallprotocol.com/view_topic.php?id=9805&forum_id=37&jump_to=113373#p113373]] s323 +  * [[https://www.marshallprotocol.com/view_topic.php?id=9805&forum_id=37&jump_to=113373#p113373]] s323 
-  * [[http://www.marshallprotocol.com/view_topic.php?id=9805&forum_id=37&jump_to=113374#p113374]] s324+  * [[https://www.marshallprotocol.com/view_topic.php?id=9805&forum_id=37&jump_to=113374#p113374]] s324
  
 . .
Line 115: Line 116:
 From: Scottk From: Scottk
 Date: 2009-11-27 20:53:34 Date: 2009-11-27 20:53:34
-Reply: http://www.marshallprotocol.com/reply.php?topic_id=12013+Reply: https://www.marshallprotocol.com/reply.php?topic_id=12013
  
 I  continued benicar throughout. after a day of MMS I could straighten my toes which I could not before and I still can now that  I have stopped MMS and resumed the full mp. My walking improved also but I am unsure if that was from stopping the abx/ip. so far the improvement in my walking has remained. I  continued benicar throughout. after a day of MMS I could straighten my toes which I could not before and I still can now that  I have stopped MMS and resumed the full mp. My walking improved also but I am unsure if that was from stopping the abx/ip. so far the improvement in my walking has remained.
Line 129: Line 130:
  
  
-We don't have an official position on this anti-microbial specifically (http://mpkb.org/doku.php/home:othertreatments), but for an ALS patient, would his experimentation be considered a specially allowed case due to this disease having more of an 'acute infection' timeline?+We don't have an official position on this anti-microbial specifically (https://mpkb.org/doku.php/home:othertreatments), but for an ALS patient, would his experimentation be considered a specially allowed case due to this disease having more of an 'acute infection' timeline?
  
  
Line 144: Line 145:
 <blockquote>Mysterious cells may play role in ALS <blockquote>Mysterious cells may play role in ALS
  
-http://www.labspaces.net/107755/Mysterious_cells_may_play_role_in_ALS+https://www.labspaces.net/107755/Mysterious_cells_may_play_role_in_ALS
  
 Although we found that the potential of these cells is more limited than previously thought, it might be possible to coax them to adopt different fates," Bergles says. "We only need to know what factors are restricting their development in the intact nervous system. Although we found that the potential of these cells is more limited than previously thought, it might be possible to coax them to adopt different fates," Bergles says. "We only need to know what factors are restricting their development in the intact nervous system.
Line 152: Line 153:
  
  
-===== References =====+===== References =====</nodisp> 
home/diseases/als.1549922348.txt.gz · Last modified: by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.